Knee surgery tourniquet mystery: why some Patients' hearts slow down when the cuff is released
NCT ID NCT07002086
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 22 patients aged 65-90 who had total knee replacement surgery. Researchers wanted to understand why some patients experience a sudden drop in heart rate and blood pressure when the tourniquet (a tight cuff that stops blood flow) is released at the end of surgery. They measured blood clotting factors and other markers before and after the tourniquet was opened. The goal was to learn how to prevent these dangerous changes in the future.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors prevent dangerous drops in heart rate and blood pressure when the tourniquet is released during knee replacement surgery.
- What could go wrong
- This is a very small, completed observational study with only 22 patients. It does not test a new treatment, so it cannot directly lead to a cure or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
22 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients undergoing knee replacement surgery
- Ages
-
65 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA score: 1-3 * primary gonarthrosis Exclusion Criteria: * ASA score 4 and above * The diagnosis of secondary gonarthrosis * Concomitant rheumatological disorders * Concomitant peripheral vascular disease * Concomitant malignant disease * Presence of organ failure * Having active infection * Use of immunosuppressive drugs * Having addiction to cigarettes, alcohol or drugs * Use of anticoagulation medicine * Presence of metabolic disease * Presence of renal disease * Presence of familial hemophagocytic syndrome * Being unwilling to participate the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Primary gonarthrosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Diyarbakır, 21070, Turkey (Türkiye)